Dr. Rittenhouse-Olson’s training includes time as a post-doctoral fellow at Roswell Park Cancer Institute (RPCI), wherein she gained clinical tumor immunology experience with T. Ming Chu, (the discoverer of Prostate Specific Antigen for diagnosis) and then carbohydrate experience with Khushi Matta. For over 25 years her University of Buffalo (UB) laboratory has been involved in studying carbohydrate tumor associated antigens, and she has studied

Dr. Sally Quataert has extensive experience and expertise in the development, validation and application of immunological methods for clinical translational research and vaccine evaluation. She has over 20 years experience in industry, with experience in regulatory compliance for GLP and GMP. Quataert has lead preclinical and clinical testing programs that provided the data supporting licensure of H.infuenzae b, Streptococcus pneumoniae, Neiser

Dr. James Olson is a University at Buffalo Distinguished Professor, with appointments in Pharmacology and Toxicology (School of Medicine and Biomedical Sciences) and Social and Preventive Medicine (School of Public Health and Health Professions), specializing in toxicology and the environmental health sciences. His research experience and expertise ranges from basic research on drug metabolism and disposition / pharmacokinetics to assessment of

Advisor, Entrepreneur-in-Residence for UB STOR assigned For-Robin. > 30 yrs’ management experience. Successful exit of a 10 yr old telecommunications services start-up (iVergent). Ran divisions for 2 multinational companies (Outokumpu OY & Schlumberger, LTD). Bob is a Board Member of the Western NY Venture Assoc.and of BeetNPath, a steel oats ready-made meal business. A MBA (UB) and a BS in Chemistry (U of Maryland).